Valneva Seeks to Extend Use of Chikungunya Vaccine with Label Extension Submissions
Sep 19, 2024
Chikungunya Invest Information
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications
Sep 18, 2024
Valneva's Innovative IXCHIQ® Becomes the First Chikungunya Vaccine Authorized in Europe
Jul 1, 2024
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva
Nov 10, 2023
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises
Nov 10, 2023